Schizophrenia
Schizophrenia is characterized by three symptom domains and affects ~1% of global population. First and mostly known are the positive symptoms like hallucinations and delusions, secondly are negative symptoms like reduced emotion and lack of motivation and the third symptom domain is cognitive symptoms like a poor memory or disorganized thinking. While there are already many drugs for treating positive symptoms, there is a significant unmet medical need for effective treatments for negative and cognitive symptoms.
Latest Articles on Schizophrenia

Schizophrenia
Living with Schizophrenia: Beyond the Stigma
Hear first-hand a patient and caregiver’s perspective of living with schizophrenia

Schizophrenia
GlyT1 Phase II study
Boehringer Ingelheim refocuses Gly-T1 inhibition brain research on schizophrenia

Schizophrenia
Can schizophrenia be prevented?
That’s what investigators are hoping to find out. Read about latest research in the field
Downloads
Introducing Decentralized Clinical Trials
Learn how the decentralized trial approach utilizes digital technology to make research more accessible to patients
Cognitive Impairment Factsheet
Learn more about this core symptom of schizophrenia, including its impact on patient quality of life.
Related Press Releases

May 25, 2021
FDA Breakthrough Therapy Designation for investigational treatment in cognitive impairment associated with Schizophrenia

September 14, 2020